Abstract
Background: Environmental factors are a major cause of poor health worldwide. The most solid evidence is for air pollution, leading to increased disability-adjusted life years. Outdoor temperature and other seasonal climate changes may also influence cardiovascular health, according to their direct modulation of air pollution. Moreover, an increasing body of evidence associates environmental exposure to noise with poor cardiovascular outcome, and in particular with hypertension.
Methods: This review is aimed at reviewing current evidence about the role of these environmental factors in cardiovascular disease and specifically hypertension. In particular, the impact of air pollution, with its short-term and long-term effects, the outdoor temperature and noise pollution will be investigated. Conclusions: People belonging to low social classes, as well as children, women, older people and those with established cardiovascular diseases, seem to have a greater susceptibility to the effects of environmental stressors, recalling the concept of “environmental justice”. The accumulating strong scientific evidence may thus support public health policies aimed at reducing social inequalities in cardiovascular health.Keywords: Air pollution, noise, hypertension, outdoor temperature, particulate matter, blood pressure.
Current Pharmaceutical Design
Title:Environmental Factors and Hypertension
Volume: 23 Issue: 22
Author(s): Rosa Maria Bruno , Marina Di Pilla , Carla Ancona , Mette Sørensen , Marco Gesi , Stefano Taddei , Thomas Munzel*Agostino Virdis *
Affiliation:
- Kardiologie I, Zentrum für Kardiologie, University Medical Center of Mainz, and DZHK-standort Rhein Main,Germany
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa,Italy
Keywords: Air pollution, noise, hypertension, outdoor temperature, particulate matter, blood pressure.
Abstract: Background: Environmental factors are a major cause of poor health worldwide. The most solid evidence is for air pollution, leading to increased disability-adjusted life years. Outdoor temperature and other seasonal climate changes may also influence cardiovascular health, according to their direct modulation of air pollution. Moreover, an increasing body of evidence associates environmental exposure to noise with poor cardiovascular outcome, and in particular with hypertension.
Methods: This review is aimed at reviewing current evidence about the role of these environmental factors in cardiovascular disease and specifically hypertension. In particular, the impact of air pollution, with its short-term and long-term effects, the outdoor temperature and noise pollution will be investigated. Conclusions: People belonging to low social classes, as well as children, women, older people and those with established cardiovascular diseases, seem to have a greater susceptibility to the effects of environmental stressors, recalling the concept of “environmental justice”. The accumulating strong scientific evidence may thus support public health policies aimed at reducing social inequalities in cardiovascular health.Export Options
About this article
Cite this article as:
Bruno Maria Rosa , Di Pilla Marina, Ancona Carla , Sørensen Mette , Gesi Marco , Taddei Stefano , Munzel Thomas *, Virdis Agostino *, Environmental Factors and Hypertension, Current Pharmaceutical Design 2017; 23 (22) . https://dx.doi.org/10.2174/1381612823666170321162233
DOI https://dx.doi.org/10.2174/1381612823666170321162233 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Therapeutic Potential of Nitrate Esters of Commonly Used Drugs
Current Topics in Medicinal Chemistry COVID-19 Severity: Lung-Heart Interplay
Current Cardiology Reviews Association of Mean Platelet Volume with Hypertension in Rheumatoid Arthritis
Inflammation & Allergy - Drug Targets (Discontinued) Perivascular Inflammation and Hypertensive Cardiovascular Remodeling
Current Hypertension Reviews Potential Cardio-Protective Effects of Green Grape Juice: A Review
Current Nutrition & Food Science Nimodipine Reappraised: An Old Drug With a Future
Current Neuropharmacology Anxiolytic-Like Effect of Underground Parts of Ajuga remota Benth (Lamiaceae) and Its Bioactive Constituents in Mice: A Behavioral Study
The Natural Products Journal Alzheimers Disease, Ceramide, Visfatin and NAD
CNS & Neurological Disorders - Drug Targets Optimizing the Management of Uncontrolled Hypertension: What do Triple Fixed-Dose Drug Combinations Add?
Current Vascular Pharmacology Mouse Models and the Role of Nitric Oxide in Reproduction
Current Pharmaceutical Design Is Elevated Norepinephrine an Etiological Factor in Some Cases of Alzheimers Disease?
Current Alzheimer Research NAD(P)H Oxidase Activation: A Potential Target Mechanism for Diabetic Vascular Complications, Progressive β-Cell Dysfunction and Metabolic Syndrome
Current Drug Targets Anti-Inflammatory Gene Therapy for Cardiovascular Disease
Current Gene Therapy Mechanisms of Endothelial Dysfunction: Clinical Significance and Preventive Non-Pharmacological Therapeutic Strategies
Current Pharmaceutical Design Marine Bioactive Peptides as Potential Antioxidants
Current Protein & Peptide Science Subject Index to Volume 3
Current Drug Targets - Cardiovascular & Hematological Disorders Genetically Modified Endothelial Progenitor Cells in the Therapy of Cardiovascular Disease and Pulmonary Hypertension
Current Vascular Pharmacology Association of Common Variants in the IL-33/ST2 Axis with Ischemic Stroke
Current Neurovascular Research Action and Disposition of the β3-Agonist Nebivolol in the Presence of Inflammation; An Alternative to Conventional β1-Blockers
Current Pharmaceutical Design Editorial: New Therapetic Approaches in the Management of Ischemia Reperfusion Injury and Cardiometabolic Diseases: Opportunities and Challenges
Current Drug Targets